07 Feb 2025
PCRonline @ ACC.25 Scientific Sessions
The Interventional Cardiology perspective!
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2025 Scientific Sessions #ACC25
Mirvat Alasnag, Elad Asher, Luigi Biasco, Aaysha Cader, Ali Nazmi Calik, Jonathan Curio, Chiara De Biase, Daniele Giacoppo, Kalaivani Mahadevan, Yohei Ohno, Luis Ortega-Paz, Nicola Ryan, Alex Sticchi and Panos Xaplanteris provide their take on what's new and what's hot in the field of interventional cardiology at ACC.25 and offer you condensed take-home messages, live from the congress. Discover the topics covered below!
Late-breaking Clinical Trials and Science to be covered:
- Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease (WARRIOR)
- Dapagliflozin in patients undergoing transcatheter aortic valve implantation (DapaTAVI) - An interview with Sergio Raposeiras-Roubin
- Stratified randomization study to compare different duration of dual antiplatelet therapy after coronary stenting in either high or low bleeding risk population (HOST-BR)
- The main results of the phase 3 Reverse-it trial - An interview with Deepak L. Bhatt
- Routine cerebral embolic protection in transcatheter aortic valve implantation: The British Heart Foundation (BHF) PROTECT-TAVI trial
- Clinical and echocardiographic outcomes among the first 500 patients treated with a dedicated transcatheter aortic valve for pure aortic regurgitation in the Align-AR clinical trial- An interview with Raj Makkar
- 5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
- Comparison of angiography-derived fractional flow reserve-guided and intravascular ultrasound-guided percutaneous coronary intervention strategies: The FLAVOUR II Trial
- Two-year outcomes of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation: The Triluminate pivotal trial - An interview with Saibal Kar
- FFR-guided PCI compared with bypass surgery: Final 5-year results of the fractional flow reserve versus angiography for multivessel evaluation 3 trial
- Clopidogrel versus aspirin for long-term maintenance monotherapy in patients with high ischemic risk after percutaneous coronary intervention
- Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial
- New insights from the early and delayed aortic valve replacement implant patients: A sub-analysis of the Early TAVR trial
- The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
- Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
- Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: Primary biomarker analysis from the EARLY TAVR Trial
